Application 209654
- Type
- ANDA
- Sponsor
- AJANTA PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 2.5MG | No | No |
| 002 | TADALAFIL | TADALAFIL | TABLET;ORAL | 5MG | No | No |
| 003 | TADALAFIL | TADALAFIL | TABLET;ORAL | 10MG | No | No |
| 004 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209654-001 | TADALAFIL | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | |
| A209654-002 | TADALAFIL | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | |
| A209654-003 | TADALAFIL | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | |
| A209654-004 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209654-001 | AB1 |
| A209654-002 | AB1 |
| A209654-003 | AB1 |
| A209654-004 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209654-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209654-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209654-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209654-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A209654-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209654-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209654-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209654-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209654-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209654-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209654-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209654-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209654-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209654-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209654-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209654-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209654-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209654-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209654-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209654-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209654-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209654-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209654-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209654-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209654-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209654-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209654-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209654-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209654-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209654-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209654-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209654-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209654-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209654-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209654-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209654-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209654-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2019-03-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209654-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2019-03-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209654-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2019-03-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209654-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2019-03-26 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209654-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209654-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209654-003 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209654-004 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A209654-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209654-002 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209654-003 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209654-004 | AB1 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A209654-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209654-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209654-003 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209654-004 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209654-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209654-002 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209654-003 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209654-004 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209654-001 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209654-002 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209654-003 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209654-004 | AB1 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209654-001 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209654-002 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209654-003 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209654-004 | AB1 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209654-001 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209654-002 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209654-003 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209654-004 | AB1 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209654-001 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209654-002 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209654-003 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209654-004 | AB1 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209654-001 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209654-002 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209654-003 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209654-004 | AB1 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209654-001 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209654-002 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209654-003 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209654-004 | AB1 | 1 | 5bbf6a4d5a75… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | A-S Medication Solutions | b1840f16-a7ea-44bd-b091-5268990aedb2 | 2026-09-09 | Warnings, Adverse reactions | 209654 ANDA209654 50090-5641 |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | c3409762-3b2b-1cfc-e053-2995a90ab91b | 2026-08-18 | Warnings, Adverse reactions | 209654 ANDA209654 68071-2421 |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | d6e8c52f-4dc3-5d54-e053-2995a90a9358 | 2026-08-03 | Warnings, Adverse reactions | 209654 ANDA209654 68071-2632 |
| Tadalafil | TADALAFIL | REMEDYREPACK INC. | 415bd983-86f3-4f38-917a-9805024f31cb | 2026-07-09 | Warnings, Adverse reactions | 209654 ANDA209654 70518-3434 |
| Tadalafil | TADALAFIL | REMEDYREPACK INC. | ad288e9d-020a-43a0-9c07-320c5c3bbc1e | 2026-05-27 | Warnings, Adverse reactions | 209654 ANDA209654 |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | 2c2ec257-06bc-4ca4-9cf3-d0f49980e374 | 2026-05-14 | Warnings, Adverse reactions | 209654 ANDA209654 71335-1823 |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | c835a34a-9bae-4d88-b951-1b78ab92f388 | 2026-05-13 | Warnings, Adverse reactions | 209654 ANDA209654 71335-1670 |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | f34e4747-28be-4ae5-ac9a-a825083b6a9b | 2026-01-12 | Warnings, Adverse reactions | 209654 ANDA209654 72789-184 |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | 7e236f83-14bf-4862-91fb-74d766aef6a9 | 2026-01-12 | Warnings, Adverse reactions | 209654 ANDA209654 |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | cf353da9-31c6-66c2-e053-2995a90a3bb0 | 2026-01-09 | Warnings, Adverse reactions | 209654 ANDA209654 68071-2554 |
| Tadalafil | TADALAFIL | Quallent Pharmaceuticals Health LLC | dc14daa3-cae9-4751-9034-b0e9c18054b4 | 2025-11-30 | Warnings, Adverse reactions | 209654 ANDA209654 |
| Tadalafil | TADALAFIL | Ajanta Pharma USA Inc. | 7e4cdac1-42cc-4038-a86b-4890962ed806 | 2025-10-10 | Warnings, Adverse reactions | 209654 ANDA209654 27241-113 27241-111 27241-114 27241-112 |
| Tadalafil | TADALAFIL | Preferred Pharmaceuticals Inc. | 2354c3e2-7b5f-4fdd-bbf2-7fa3c57686f8 | 2025-09-25 | Warnings, Adverse reactions | 209654 ANDA209654 68788-8292 |
| Tadalafil | TADALAFIL | Preferred Pharmaceuticals Inc. | 761dc0f8-2f65-4615-ab49-a4bcffd40ce9 | 2025-09-25 | Warnings, Adverse reactions | 209654 ANDA209654 |
| TADALAFIL | TADALAFIL | direct rx | b3ee8325-bcb2-43fd-e053-2a95a90a08c8 | 2025-07-09 | Warnings, Adverse reactions | 209654 ANDA209654 72189-145 |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | 0a9cf85a-c17d-6890-e063-6394a90a93e9 | 2025-03-04 | Warnings, Adverse reactions | 209654 ANDA209654 |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | 85ed0cbc-df84-44df-a9eb-f9587dbc21df | 2024-08-21 | Warnings, Adverse reactions | 209654 ANDA209654 71335-1491 |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | 185a3284-3a4f-44d3-9278-98581d33f95b | 2024-08-08 | Warnings, Adverse reactions | 209654 ANDA209654 63629-8288 |
| Tadalafil | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | 6213fd38-9580-4253-91d2-14c28a711c20 | 2023-08-28 | Warnings, Adverse reactions | 209654 ANDA209654 |
| Tadalafil | TADALAFIL | Asclemed USA, Inc. | 5ea24573-2d16-40d8-a46c-7b5fa8669e69 | 2023-03-28 | Warnings, Adverse reactions | 209654 ANDA209654 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 27241-111 | Tadalafil | Tadalafil | Ajanta Pharma USA Inc. | ANDA | Current |
| 27241-111 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-111 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-111 | Tadalafil | Tadalafil | Ajanta Pharma USA Inc. | ANDA | Current |
| 27241-111 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-111 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-112 | Tadalafil | Tadalafil | Ajanta Pharma USA Inc. | ANDA | Current |
| 27241-112 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-112 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-112 | Tadalafil | Tadalafil | Ajanta Pharma USA Inc. | ANDA | Current |
| 27241-112 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-112 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-113 | Tadalafil | Tadalafil | Ajanta Pharma USA Inc. | ANDA | Current |
| 27241-113 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-113 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-113 | Tadalafil | Tadalafil | Ajanta Pharma USA Inc. | ANDA | Current |
| 27241-113 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-113 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-114 | Tadalafil | Tadalafil | Ajanta Pharma USA Inc. | ANDA | Current |
| 27241-114 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-114 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-114 | Tadalafil | Tadalafil | Ajanta Pharma USA Inc. | ANDA | Current |
| 27241-114 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 27241-114 | Tadalafil | Tadalafil | Ajanta Pharma Limited | ANDA | Current |
| 50090-5344 | Tadalafil | Tadalafil | A-S Medication Solutions | ANDA | Current |
| 50090-5641 | Tadalafil | Tadalafil | A-S Medication Solutions | ANDA | Current |
| 50436-0114 | Tadalafil | Tadalafil | Unit Dose Services | ANDA | Current |
| 50436-1120 | Tadalafil | Tadalafil | Unit Dose Services | ANDA | Current |
| 50436-1120 | Tadalafil | Tadalafil | Unit Dose Services | ANDA | Current |
| 63629-8288 | Tadalafil | Tadalafil | Bryant Ranch Prepack | ANDA | Current |
| 63629-8288 | Tadalafil | Tadalafil | Bryant Ranch Prepack | ANDA | Current |
| 68071-2417 | Tadalafil | Tadalafil | NUCARE PHARMACEUTICALS INC | ANDA | Current |
| 68071-2417 | Tadalafil | Tadalafil | NUCARE PHARMACEUTICALS INC | ANDA | Current |
| 68071-2421 | Tadalafil | Tadalafil | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2421 | Tadalafil | Tadalafil | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2421 | Tadalafil | Tadalafil | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2421 | Tadalafil | Tadalafil | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2451 | Tadalafil | Tadalafil | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2554 | Tadalafil | Tadalafil | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2613 | Tadalafil | Tadalafil | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2632 | Tadalafil | Tadalafil | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68788-8292 | Tadalafil | Tadalafil | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 70518-3434 | Tadalafil | Tadalafil | REMEDYREPACK INC. | ANDA | Current |
| 70518-3434 | Tadalafil | Tadalafil | REMEDYREPACK INC. | ANDA | Current |
| 70518-3434 | Tadalafil | Tadalafil | REMEDYREPACK INC. | ANDA | Current |
| 71205-734 | Tadalafil | Tadalafil | Proficient Rx LP | ANDA | Current |
| 71205-735 | Tadalafil | Tadalafil | Proficient Rx LP | ANDA | Current |
| 71205-736 | Tadalafil | Tadalafil | Proficient Rx LP | ANDA | Current |
| 71335-1491 | Tadalafil | Tadalafil | Bryant Ranch Prepack | ANDA | Current |
| 71335-1491 | Tadalafil | Tadalafil | Bryant Ranch Prepack | ANDA | Current |
| 71335-1491 | Tadalafil | Tadalafil | Bryant Ranch Prepack | ANDA | Current |
| 71335-1670 | Tadalafil | Tadalafil | Bryant Ranch Prepack | ANDA | Current |
| 71335-1670 | Tadalafil | Tadalafil | Bryant Ranch Prepack | ANDA | Current |
| 71335-1670 | Tadalafil | Tadalafil | Bryant Ranch Prepack | ANDA | Current |
| 71335-1823 | Tadalafil | Tadalafil | Bryant Ranch Prepack | ANDA | Current |
| 71610-461 | Tadalafil | Tadalafil | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 72189-145 | TADALAFIL | TADALAFIL | direct rx | ANDA | Current |
| 72789-184 | Tadalafil | Tadalafil | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-184 | Tadalafil | Tadalafil | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |